Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Knightscope
Sponsored
content by Knightscope
MA
MarketJar
Community Contributor
The Next Phase of Defense AI: A Robotic Response to America’s Security Gaps
Autonomous systems are no longer just a futuristic vision — they’re fast becoming an essential layer of national security. As AI reshapes everything from finance to warfare, physical security remains one of the most under-addressed frontiers.
View narrative
US$12.00
FV
54.3% undervalued
intrinsic discount
22.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
1
users have commented on this narrative
15
users have followed this narrative
New
narrative
Figma
TI
TickerTickle
Community Contributor
Figma (FIG): The S&P 500’s Design Standard Turning Into an All-in-One Platform
Watching Figma Grow Up I’ve been using Figma almost every single day for the past five years. As a product designer, it’s been my main tool for designing interfaces, testing and prototyping ideas, and also for working together with teams in different countries and time zones.
View narrative
US$65.70
FV
7.2% overvalued
intrinsic discount
30.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
Updated
narrative
Sleep Cycle
MA
Mandelman
Community Contributor
Sleep Cycle's Revenue Set to Rise 10% with Strong Revenue Model
Update Q1 2025 (updated 250510) The latest user‐growth data suggest headwinds for top-line revenue, but management’s active repricing initiatives should help offset this. By combining modest user gains with targeted price increases, the company can still drive overall revenue growth.
View narrative
SEK 38.04
FV
25.3% undervalued
intrinsic discount
3.15%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
Updated
narrative
JB Hi-Fi
RO
Robbo
Community Contributor
Has JB Hi-Fi Lost Its Point of Difference?
I may be showing my age here, but I feel that a decade or so ago, shopping at JB Hi-Fi was a different experience. There seemed to be a deliberate policy of employing sales staff from alternative subcultures, which gave the stores a unique, edgy vibe.
View narrative
AU$76.00
FV
51.4% overvalued
intrinsic discount
-0.45%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Alkyl Amines Chemicals
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Persistent Oversupply And Strict Regulations Will Burden Future Performance
Key Takeaways Persistent oversupply, rising competition, and volatile input costs are depressing margins and limiting revenue growth prospects for Alkyl Amines. Costly upgrades for environmental compliance and declining export opportunities are further straining profitability and earnings stability.
View narrative
₹2.03k
FV
4.4% overvalued
intrinsic discount
22.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
Alembic Pharmaceuticals
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Regulatory Scrutiny And Supply Issues Will Squeeze Pharma Prospects
Key Takeaways Increased regulatory, compliance, and geopolitical pressures risk inflating costs, delaying launches, and destabilizing Alembic's overseas revenue streams. Heavy US market dependence and lag in biologics threaten market share, margins, and future earnings amid industry shifts and intensifying competition.
View narrative
₹900.00
FV
8.7% overvalued
intrinsic discount
9.99%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
EnerSys
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
US Communications And Data Centers Will Fuel Storage Demand
Key Takeaways Growth in digital infrastructure, electrification, and automation is boosting demand for EnerSys' advanced storage solutions and fueling multi-year revenue and margin expansion. Strategic cost reductions, tech integration, and targeted acquisitions are widening EnerSys' market reach and driving structural improvements in profitability.
View narrative
US$111.69
FV
9.2% undervalued
intrinsic discount
1.97%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
21
users have followed this narrative
6 days ago
author updated this narrative
Tokyu
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Shibuya Redevelopment Will Struggle As Urban Demand Falls
Key Takeaways Demographic shifts, suburbanization, and new mobility trends are set to erode core demand, undermining Tokyu's revenue growth and diversification strategies. High capital and labor costs, along with regional concentration, risk compressing margins and diminishing profitability if market conditions deteriorate.
View narrative
JP¥1.80k
FV
3.4% overvalued
intrinsic discount
2.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
Nedbank Group
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Legacy IT And Rising Regulatory Burdens Will Weigh On Prospects
Key Takeaways Weak digital transformation and legacy IT systems risk accelerating customer attrition and diminish Nedbank's relevance amid aggressive fintech competition. Heavy reliance on a challenging domestic market and rising regulatory costs threaten profitability and heighten exposure to demographic and economic headwinds.
View narrative
R239.00
FV
4.8% undervalued
intrinsic discount
9.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
3034
Novatek Microelectronics
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
Chinese Subsidies And Tech Shifts Will Shrink Addressable Markets
Key Takeaways Slowing demand growth and rising competition threaten Novatek's top-line performance and could compress margins in key segments. Advanced technology shifts and stricter global regulations risk eroding core market relevance and driving up operational costs.
View narrative
NT$400.00
FV
7.6% overvalued
intrinsic discount
0.91%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
Alinma Bank
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
Saudi Banking Competition And Rising Costs Will Squeeze Margins
Key Takeaways Intensifying competition and digital disruption are compressing margins and threatening Alinma's traditional customer base and revenue streams. High operating expenses and regulatory pressures risk eroding profitability and hindering sustainable long-term growth.
View narrative
ر.س26.70
FV
3.1% undervalued
intrinsic discount
10.41%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
16 days ago
author updated this narrative
Healwell AI
AN
AnalystHighTarget
Consensus Narrative from 11 Analysts
Digital Transformation And AI Solutions Will Transform Healthcare Globally
Key Takeaways Integration with Orion Health and proprietary AI tools could drive rapid uptake, recurring high-margin revenue, and outsized earnings growth well above sector norms. Unique market positioning and strategic partnerships provide resilience and strong advantages for capturing major public sector contracts amid global healthcare digital transformation.
View narrative
CA$5.00
FV
73.2% undervalued
intrinsic discount
78.02%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
Tokyo Electron
AN
AnalystLowTarget
Consensus Narrative from 22 Analysts
Cautious Capex Cuts And Rising Costs Will Hurt Semiconductor Outlook
Key Takeaways Prolonged customer caution, industry competition, and shifting regulatory demands threaten to compress margins and stall growth across key customer segments and geographies. Heavy reliance on top customers and the Chinese market heightens exposure to abrupt sales declines amid rising local competition and policy uncertainties.
View narrative
JP¥21.74k
FV
7.2% undervalued
intrinsic discount
3.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
Value any company in seconds
Popular companies